1.8300
31-October-24 15:44:47
15 minutes delayed
Stocks
-0.0400
-2.14%
Today's range
1.8100 - 2.0299
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 09:00:00 By Nasdaq GlobeNewswire